Salix Pharmaceuticals Inc (SLXP)
Quote as of 4:00 PM ET 03/10/2010 (NASDAQ GS)
| Last: 31.49 |
Change: $0.26 |
Percent Change: 0.83 |
Volume: 1,257,597 |
Salix Pharmaceuticals, Ltd. is a specialty pharmaceutical company focuses on acquiring, developing and commercializing prescription drugs used in the treatment of a range of gastrointestinal diseases, which are those affecting the digestive tract. As of December 31, 2008, the Company?s products were XIFAXAN (rifaximin) Tablets 200 milligram; MOVIPREP; OSMOPREP, VISICOL Tablets, AZASAN Azathioprine Tablets, USP, 75/100 milligram; ANUSOL-HC 2.5% (Hydrocortisone Cream, USP), ANUSOL-HC 25 milligram Suppository (Hydrocortisone Acetate); PROCTOCORT Cream (Hydrocortisone Cream, USP) 1% and PROCTOCORT Suppository (Hydrocortisone Acetate Rectal Suppositories) 30 milligram; PEPCID (famotidine) for Oral Suspension; Oral Suspension DIURIL (Chlorothiazide); APRISO (mesalamine) extended-release capsules 0.375 grams, and COLAZAL (balsalazide disodium) Capsules 750 milligram.
Analyst Opinions
| |
Current |
1 Mo. |
3 Mo. |
| Strong Buy |
9.00 |
6.00 |
6.00 |
| Buy |
0.00 |
0.00 |
1.00 |
| Hold |
1.00 |
2.00 |
2.00 |
| Sell |
0.00 |
0.00 |
0.00 |
| Strong Sell |
0.00 |
0.00 |
0.00 |
|
|
Average Recommendation
| Current |
1.10 |
| 1 Mo. Ago |
1.25 |
| 3 Mo. Ago |
1.28 |
Recommendation Scale
| Strong Sell: 3.0 |
Hold: 2.0 |
Strong Buy: 1.0 |
|